Biogel
Biogel, officially known as Biogel AG, is a leading player in the biotechnology sector, headquartered in Switzerland (CH). Founded in the early 2000s, the company has established a strong presence in Europe and beyond, focusing on innovative biopharmaceutical solutions. Specialising in the development of advanced biomaterials and medical devices, Biogel is renowned for its unique product offerings that enhance patient care and surgical outcomes. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted name in the industry. With a robust portfolio that includes cutting-edge wound care products and surgical adhesives, Biogel continues to set benchmarks for quality and efficacy. Its dedication to innovation and excellence has earned it a prominent market position, making it a preferred choice among healthcare professionals worldwide.
DitchCarbon Score
How does Biogel's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biogel's score of 9 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Biogel's reported carbon emissions
In 2020, Biogel AG reported total greenhouse gas emissions of approximately 43,477,000 kg CO2e for Scope 1, 53,463,000 kg CO2e for Scope 2, and 19,506,000 kg CO2e for Scope 3. This data highlights the company's significant carbon footprint across all scopes of emissions, with Scope 2 emissions being the highest contributor. Biogel AG has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 greenhouse gas emissions by 42% by 2030, using 2019 as the base year. This target has been approved through a streamlined validation route for small and medium-sized enterprises (SMEs) and aligns with the necessary reductions to limit global warming to 1.5°C. Additionally, the company is committed to measuring and reducing its Scope 3 emissions, further demonstrating its dedication to comprehensive climate action. Overall, Biogel AG's proactive approach to addressing its carbon emissions reflects its commitment to sustainability and responsible environmental stewardship within the pharmaceuticals, biotechnology, and life sciences sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2018 | 2019 | 2020 | |
|---|---|---|---|
| Scope 1 | 27,638,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 49,426,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 22,124,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biogel is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
